Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1465 publications
Companion Diagnostic Tests In Oncology - South America Analysis and Market Forecasts US$ 4,450.00

Companion Diagnostic Tests In Oncology - South America Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... report focuses on the companion diagnostic testing markets in South America to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face ...

Dec, 2016
Companion Diagnostic Tests in Oncology - North America Analysis and Market Forecasts US$ 4,450.00

Companion Diagnostic Tests in Oncology - North America Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... report focuses on the companion diagnostic testing markets in North America to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face ...

Dec, 2016
Companion Diagnostic Tests in Oncology - Current and Future Players US$ 3,500.00

Companion Diagnostic Tests in Oncology - Current and Future Players SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... needs in the global market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face of rapid technological advancement. The four ...

Dec, 2016
Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts US$ 4,450.00

Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... companion diagnostic testing markets in Japan, China and India, to identify unmet needs in the APAC market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing ...

Dec, 2016
Companion Diagnostic Tests in Oncology - 5EU Analysis and Market Forecasts US$ 4,450.00

Companion Diagnostic Tests in Oncology - 5EU Analysis and Market Forecasts SUMMARY Companion diagnostics is ... companion diagnostic testing markets in Europe to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing ...

Dec, 2016
Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific,... US$ 4,950.00

The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand ... the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment Some of the major companies operating in this market ...

Feb, 2017 90 pages
United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,700.00

The United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview ... 4 company 5 company 6 company 7 company 8 company 9 United States Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III United States Cervical Cancer Vaccine Market: Application Segment Analysis Application ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Sales Market Report Forecast 2017-2021 US$ 3,800.00

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 2,800.00

The Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Global Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III Global Cervical Cancer Vaccine Market: Application ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Market Professional Survey Report Forecast 2017-2021 US$ 3,400.00

This report studies Cervical Cancer Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and ... to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering MSD GSK ...

Feb, 2017 112 pages
Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,800.00

The Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... in the market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Europe Cervical Cancer Vaccine Market Analysis by Product: Type I Type II Type III Europe Cervical Cancer Vaccine Market Analysis ...

Feb, 2017 112 pages
China Corneal Punch Market Research Report Forecast 2017-2021 US$ 3,000.00

The China Corneal Punch Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Corneal Punch industry overview with ... UltraFit company 6 company 7 company 8 company 9 China Corneal Punch Market: Product Segment Analysis Type I Type II Type III China Corneal Punch Market: Application Segment Analysis Application 1 Application 1I Application ...

Feb, 2017 114 pages
China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,100.00

The China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 China Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III China Cervical Cancer Vaccine Market: Application ...

Feb, 2017 112 pages
US Cancer Generics Market Outlook 2022 US$ 1,500.00

... . “US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market ...

Feb, 2017 100 pages
Personalized Cancer Vaccines Market & Clinical Innovation Outlook 2022 US$ 2,000.00

... Personalized Cancer Vaccines Identification of Tumor Neoantigens Development & Mechanism of Personalized Vaccines Categories of Personalized Cancer Vaccines Biomarkers for Personalized Vaccines Personalized Vaccines for Multiple Cancers Current & Future Market Outlook of Personalized Cancer Vaccines ...

Feb, 2017 170 pages
Colorectal Cancer - Heat Map and Analysis US$ 2,000.00 US$ 1,700.00

Colorectal Cancer - Heat Map and Analysis Summary Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of ... ? What are the clinical characteristics of currently approved therapies for colorectal cancer, in terms of specific safety and efficacy parameters? How are clinical ...

Feb, 2017 21 pages
2017 North America Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities US$ 10,500.00

... sales forecasts for major cancer diagnostic assays. Instrumentation Review Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their ... potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection ...

Feb, 2017 630 pages
2017 Middle East Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities US$ 9,850.00

... potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies ...

Feb, 2017 530 pages
2017 Latin America Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities US$ 7,850.00

... potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies ...

Feb, 2017 550 pages
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities US$ 45,000.00

... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

Feb, 2017 935 pages
2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities US$ 14,500.00

... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

Feb, 2017 1450 pages
Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast US$ 1,990.00

... Global Cervical Cancer Screening Market, Forecast and by Countries? What is Global Pap Smear Screening Market and by Countries? What is Global HPV DNA Screening Market, Forecast and by Countries? What is Global ...

Feb, 2017 238 pages
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 US$ 10,995.00 US$ 9,345.75

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 SUMMARY Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype ...

Nov, 2016 608 pages
Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021) US$ 800.00

... would overcome resistance and prevent recurrence of the disease. The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare ... report “Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with ...

Feb, 2017 70 pages
Global Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2022 US$ 1,990.00

... top contributors to the global breast cancer screening population. This is the 2nd edition report on breast cancer screening market by iGATE RESEARCH. The report titled “Global Breast Cancer Screening (Mammography, MRI and Ultrasound ... Screening Population and Forecast 5. Breast Cancer Mammography Screening Market and Forecast 6. Breast Cancer MRI Screening Market and Forecast 7. Breast Cancer Ultrasound Screening Market and Forecast 8. Global Breast Cancer Screening Market - Drivers and Challeng

Feb, 2017 532 pages
The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests US$ 1,109.00

... . is oriented to collaborative co-diagnostics development. These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests’. This unique and comprehensive report identifies and profiles the leading 100 developers of cancer in-vitro ...

Feb, 2017 180 pages
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population US$ 4,500.00

... Stage Prostate Cancer Pipeline drugs – AKT inhibitors or PARP inhibitors or a new MoA combination with Antiandrogen or IO combo - Competing to Xtandi/Zytiga or targeting Xtandi/Zytiga Resistance Population? Increase in prevalence of Prostate cancer ...

Feb, 2017 200 pages
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) US$ 1,250.00

... Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015. Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is 119 Page market ...

Jan, 2017 120 pages
Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America US$ 1,000.00

... testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests. Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America ...

Jan, 2017 49 pages
2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers,... US$ 68,600.00

... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

Jan, 2017 1450 pages
2017-2022 Global Top Countries Cancer Treatment Drugs Market Report US$ 4,960.00

... Countries, this report splits Global into several key Countries, with sales, revenue, market share of top 5 players in these Countries, from 2012 to 2017 ...

Jan, 2017 135 pages
Urinary Tract Cancer Market: By Type (Squamous Cell Carcinoma, Transitional Cell Carcinoma, Others); By Diagnostic Tools (Biopsy, Cystoscopy, Others); By Treatment (Biological Therapy,... US$ 5,250.00

... types of urinary tract cancer, urothelial carcinoma has the highest market share in the urinary tract cancer market due to a higher occurrence rate of approximately 90%. This report identifies the urinary tract cancer market size ... with respect to the urinary tract cancer market. This report segments the urinary tract cancer market on the basis of type, diagnostic tools, treatment, and regional market as follows: Urinary Tract Cancer Market, By Type: Squamous ...

Sep, 2016 165 pages
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global... US$ 3,000.00

... therapy is expected to be a game-changing approach to treating cancer. The report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application ... report also provides the sales of major marketed Immuno-oncology drugs. On the basis of type of product, the global Immuno-oncology market has been segmented into major product ...

Jan, 2017 145 pages
2017 Vietnam Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Venezuela Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 United Arab Emirates Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales... US$ 4,850.00

... others. Instrumentation Review Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling ... . Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments ...

Jan, 2017 535 pages
2017 Thailand Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Taiwan Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 South Korea Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

Jan, 2017 535 pages
2017 South Africa Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

Jan, 2017 535 pages
2017 Singapore Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Serbia Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Saudi Arabia Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...

Jan, 2017 535 pages
2017 Qatar Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Philippines Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Peru Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Pakistan Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Oman Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 Nigeria Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...

Jan, 2017 535 pages
2017 New Zealand Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments of major ...

Jan, 2017 535 pages
1 2 3 4 5 >
Skip to top